Skip to main content
. 2020 Jan 30;9(2):96–105. doi: 10.1002/psp4.12487

Figure 1.

Figure 1

Schematic representation of the clinical study design for SHH4812g (a) and the stacked bar plots for the observed longitudinal profiles of muscle spasm in SHH4812g based on weekly spaced data set (b). AE, adverse event; CHC, complete histologic clearance; d, days; F/U, follow‐up; PK, pharmacokinetics; Tx, treatment.